Status:
UNKNOWN
Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients
Lead Sponsor:
Assiut University
Conditions:
Neo-adjuvant Short Course Chemo-radiotherapy in Locally Advanced Cancer Rectum
Eligibility:
All Genders
20-80 years
Phase:
PHASE2
PHASE3
Brief Summary
* The primary objective of this trial is to assess the safety and feasibility of 5-FU when given concurrently with5 Gy x 5 fractions IMRT. * The secondary endpoint is to assess disease local control a...
Detailed Description
Neo-adjuvant radiotherapy is associated with the improvement of local control for rectal cancer. For locally advanced stage II-III resectable rectal cancer, either preoperative short-course radiothera...
Eligibility Criteria
Inclusion
- Pathological confirmed cancer rectum
- Age between 20-80
- Clinical T3\\4 or node positive disease by MRI
Exclusion
- Early stage cancer rectum
- M1 disease confirmed by imaging or pathological
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04370418
Start Date
May 1 2020
End Date
September 1 2023
Last Update
February 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Assuit, Egypt, 71515